On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Save 20% on Press Releases and More with NNW Prime! Click to View Details
TuesdayMay 16, 2017 12:23 pm

NetworkNewsBreaks – Top 10 Mid-day Percentage Gainers on May 16, 2017

Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage: EOSS 25.00% – News: Acquires trading base in Taiwan NDEV 17.82% – News: Posts Q1 2017 financial results SPYR 11.86% – News: Develops new Pocket Starships player vs. player feature BHTG 9.47% – News: Posts Q1 2017 financial results LOTE 9.31% – News: Submits proposal on $5M supply and service project GRWG 9.12% – News: Posts Q1 2017 financial results NHLD 6.00% – News: Posts fiscal Q2 2017 financial results NEPT 6.00% – News:…

Continue Reading

TuesdayMay 16, 2017 12:20 pm

NetworkNewsBreaks – Great Basin Scientific, Inc. (GBSN) Commences Commercial Launch of Bordetella Direct Test in U.S.; Receives CE Marking in EU

Great Basin Scientific (OTCQB: GBSN) this morning said it is initiating the U.S. commercial launch of its Bordetella Direct Test. The company also said it has received CE Marking designation under the European Directive on In Vitro Diagnostic Medical Devices, marking the company’s sixth assay to receive CE Marking under the directive. The Bordetella Direct Test also increases the company’s commercially available assays in the U.S. to five. “The processes we put in place that resulted in a swift FDA clearance also supported our ability to quickly commercialize the Bordetella Direct Test, much to the relief of many of our…

Continue Reading

TuesdayMay 16, 2017 12:18 pm

NetworkNewsBreaks – Mirna Therapeutics, Inc. (NASDAQ: MIRN) Shares Plummet On Merger Agreement with Synlogic

Shares of Mirna Therapeutics (NASDAQ: MIRN) dropped 23% after the company announced its definitive merger agreement with Synlogic, Inc. Per the agreement, Synlogic will merge with a wholly owned subsidiary of Mirna in an all-stock transaction. The merged company will focus on advancing Synlogic’s drug discovery and development platform for Synthetic Biotic medicines and operate under the Synlogic name. Synlogic also recently closed a $42 million Series C preferred stock financing from leading biotechnology investors to finance the merged company. “Following a thorough review of strategic alternatives, we are delighted to announce this transaction with Synlogic, which we believe is…

Continue Reading

TuesdayMay 16, 2017 12:14 pm

NetworkNewsBreaks – ChinaNet Online Holdings (NASDAQ: CNET) Trims Net Loss, Increases Revenues in Q1 2017

ChinaNet Online Holdings (NASDAQ: CNET) this morning reported a 43.6% YoY increase in first-quarter revenues, sending shares 12% higher in mid-morning trade. For the three months ended March 31, 2017, total revenues increased to $7.3 million from $5.1 million in the prior year. The increase is primarily due to sales of the company’s search engine marketing, which increased 252.1% to $5.0 million. Alternatively, revenues from Internet advertising and data services were $2.3 million, a decrease of 36.8% from $3.6 million in the first quarter of 2016. Gross profit for the first quarter of 2017 was $1.3 million compared to $1.6…

Continue Reading

TuesdayMay 16, 2017 10:37 am

NetworkNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) Adds Craig Cheifetz, M.D. to Advisory Team

India Globalization Capital, Inc. (NYSE MKT: IGC), a developer of cannabis-based therapies to treat a variety of life-altering conditions, this morning announced that Craig Cheifetz, M.D. has joined the company as an advisor to provide guidance on clinical trials, biotechnology, neuroscience, immunology and microbiology. “I welcome Dr. Cheifetz to the IGC advisory team and look forward to his contributions as we move forward in developing cannabis-based, combination therapies,” Ram Mukunda, CEO of IGC, stated in the news release. “We remain committed to accelerating our initiatives and building a robust portfolio of compounds to address large market conditions.” Cheifetz currently serves…

Continue Reading

TuesdayMay 16, 2017 9:04 am

NetworkNewsBreaks – Net Element, Inc. (NASDAQ: NETE) Records 20% YOY Revenue Growth in First Quarter of 2017

Mobile payment technology company Net Element, Inc. (NASDAQ: NETE), in a news release issued late Monday, reported its financial results for the first quarter of 2017. Among the highlights, the company recorded net revenues of $13,561,941, marking a year-over-year increase of 20 percent. Net Element attributed this performance to organic growth in its North America Transaction Solutions segment, which demonstrated a year-over-year net revenue increase of 40 percent. Similarly, the company’s Online Solutions segment recorded a 23 percent year-over-year increase in revenues, which was attributed to continued organic growth in global online payment acceptance services with an emphasis on value-added…

Continue Reading

MondayMay 15, 2017 4:27 pm

NetworkNewsBreaks – SRAX (NASDAQ: SRAX) Reports First Quarter 2017 Results, Management Reaffirms 2017 Guidance

Internet advertising company SRAX (NASDAQ: SRAX) today reported its first quarter 2017 financial results. Among the highlights, the company recorded quarterly revenue of $5.3 million with gross profit of $2 million. SRAX reported a net loss of $2 million for the three-month period, compared to a loss of $2.4 million in the first quarter of 2016. “Over the past year, we have expanded our offering, creating new high growth revenue streams like SRAX Reach, and established a leaner infrastructure,” Christopher Miglino, CEO and chairman of SRAX, stated in the news release. “While not evident in our first quarter financial results…

Continue Reading

MondayMay 15, 2017 2:19 pm

NetworkNewsBreaks – Top 10 Mid-day Percentage Gainers on May 15, 2017

Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage: ESDI 22.78% – News: Posts Q1 2017 financial results EKSO 15.95% – News: Provides update on the stroke rehabilitation market on CNBC’s “On the Money” IDXG 12.97% – News: Posts Q1 2017 financial results, hosting conference call at 4:30pm ET CYRN 12.50% – News: Issues customer update regarding WannaCry CAAS 10.36% – News: Receives preliminary non-binding "going private" proposal SINO 9.85% – News: Posts Q3 fiscal 2017 financial results AMSC 9.54% – News: Enters…

Continue Reading

MondayMay 15, 2017 12:21 pm

NetworkNewsBreaks – Windstream (NASDAQ: WIN) Awarded 2017 Most Valuable Employers for Military®; Opens Five Fiber Routes Nationwide

Shares of Windstream’s (NASDAQ: WIN) are 6% higher on news that RecruitMilitary has awarded the company as a 2017 Most Valuable Employers (MVE) for Military®. MVEs are chosen annually based on employers that have recruiting, training and retention plans that best serve military service members and veterans. The award is marking its ninth edition in 2017. Additionally, the company said today that it is opening five strategically located fiber routes on its nationwide long-haul fiber transport network. “We are committed to welcoming veterans into our ranks because they bring experiences, technical skills and leadership attributes that make us a stronger…

Continue Reading

MondayMay 15, 2017 12:18 pm

NetworkNewsBreaks – Aegis Capital Reiterates “Buy” Rating on Nektar Therapeutics (NASDAQ: NKTR)

Following the release of Nektar Therapeutics’ (NASDAQ: NKTR) first-quarter results, Aegis Capital reiterated its ‘Buy’ rating and price target of $27 on shares of the company’s stock. Though Nektar’s first-quarter revenue of $24.7 million fell short of the consensus of $30.9 million, the Aegis analyst noted the company’s multiple product candidates awaiting approval and potential upcoming product launches as the area of focus. Additionally, Nektar recently reported positive top-line data for the phase 3 Summit-07 trial evaluating NKTR-181 in chronic lower back pain. Readout for the ongoing pivotal trial is anticipated in mid-summer 2017. For more information, visit www.nektar.com About Nektar…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 212.418.1217